Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal

BSE3137.0548.05 (+1.56 %)

PREV CLOSE ( ) 3089.00

OPEN PRICE ( ) 3072.35

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 13997

TODAY'S LOW / HIGH ( )3064.00 3210.20

52 WK LOW / HIGH ( )2295.1 3542.6

NSE3135.5046.1 (+1.49 %)

PREV CLOSE( ) 3089.40

OPEN PRICE ( ) 3089.90

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 3135.50 (56)

VOLUME 528369

TODAY'S LOW / HIGH( ) 3063.00 3208.90

52 WK LOW / HIGH ( )2293.55 3540

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

7306

6698

6026

5967

Total Expenditure

5065

4775

4336

4427

PBIDT (Excl OI)

2241

1923

1690

1540

Other Income

248

281

258

251

Operating Profit

2489

2204

1948

1791

Interest

Exceptional Items

PBDT

2441

2157

1898

1738

Depreciation

405

346

364

355

Profit Before Tax

2036

1811

1534

1383

Tax

514

471

-21

402

Provisions and contingencies

Profit After Tax

1522

1340

1555

981

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1522

1340

1555

981

Minority Interest

-16

-7

-14

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1506

1324

1548

967

Equity Capital

838

836

Face Value (IN RS)

Reserves

Calculated EPS

17.97

15.79

18.51

11.56

Calculated EPS (Annualised)

71.88

63.19

74.06

46.26

No of Public Share Holdings

39194375

38714375

38530600

38526600

% of Public Share Holdings

46.79

46.21

46.09

PBIDTM% (Excl OI)

30.67

28.71

28.04

25.80

PBIDTM%

34.06

32.90

32.32

30.01

PBDTM%

33.41

32.20

31.49

29.12

PBTM%

27.86

27.03

25.45

23.17

PATM%

20.83

20.00

25.80

16.44

Notes

Risk Disclosures on Derivatives

Quarterly Results

DR. LAL PATHLABS LTD.